← Open Payments lookup

CHEANN LEGASPI: Open Payments

NPI 1720660848 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,885 in 75 payments from 10 companies in 2025. Trend: 2023 $1,579 · 2024 $1,737 · 2025 $1,885

Food & beverage: $1,698Education: $187
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.18$492
Vanda Pharmaceuticals Inc.10$208
E.R. Squibb & Sons, L.L.C.10$198
ACADIA Pharmaceuticals Inc5$188
Otsuka America Pharmaceutical, Inc.9$186
Neurocrine BioSciences, Inc.7$166
Alkermes, Inc.3$162
ABBVIE INC.8$149
Janssen Pharmaceuticals, Inc3$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46

Products named: FANAPT, COBENFY, AUSTEDO XR, NUPLAZID, INGREZZA, VRAYLAR, REXULTI, LYBALVI.

Industry payments across CA — which companies pay providers there.